1995
DOI: 10.1016/0962-8479(95)90014-4
|View full text |Cite
|
Sign up to set email alerts
|

Control of drug-resistant tuberculosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
20
0
3

Year Published

2000
2000
2019
2019

Publication Types

Select...
4
3
1

Relationship

1
7

Authors

Journals

citations
Cited by 34 publications
(23 citation statements)
references
References 12 publications
0
20
0
3
Order By: Relevance
“…Novel mutations in a growing population will eventually lead to MDR-TB, if the inadequate treatment continues (irregular). Inadequate treatment can be defined as direct or indirect monotherapy, and this can be related to the health professional, to the drug, or to the patient himself (38,39) .…”
Section: Resultsmentioning
confidence: 99%
“…Novel mutations in a growing population will eventually lead to MDR-TB, if the inadequate treatment continues (irregular). Inadequate treatment can be defined as direct or indirect monotherapy, and this can be related to the health professional, to the drug, or to the patient himself (38,39) .…”
Section: Resultsmentioning
confidence: 99%
“…Estudo publicado por Lambregts-van Weezenbeek e Veen, em 1995, mostra a importância do fornecimento de medicação no decorrer do desenvolvimento da TBMR. (13) Em pesquisa publicada por Natal em 1993, a falta de medicação aparece como causa de não-adesão ao tratamento. (27) No presente estudo a falta de medicação aparece como fator de risco para tratamento inadequado (Tabela 1).…”
Section: Fatores Associados Aos Tratamentos Inadequados Em Grupo De Punclassified
“…Esse estado reflete a acumulação de etapas de mutações individuais de diversos genes independentes, e não à aquisição em bloco de resistência a múltiplas drogas. (12) Tratamento inadequado pode ser definido como monoterapia direta ou indireta (13)(14)(15) e isso pode estar relacionado ao profissional de saúde, à droga ou ao próprio paciente. Muitos pesquisadores têm publicado que tratamento irregular é fator de risco para TBMR.…”
Section: Introductionunclassified
“…Since standard treatment regimens [10] constitute the best means of prevention of drug resistance, results of antituberculosis drug resistance surveillance are mainly useful in the design of interventions for implementing such regimens or improving their use, e.g. by improving drug prescription or delivery, patient follow-up and adherence to therapy [9]. 2) Identification of population groups at high risk of drug resistance in order to target interventions for preventing the development and transmission of drugresistant tuberculosis.…”
Section: Objectives Of Antituberculosis Drug Resistance Surveillancementioning
confidence: 99%
“…Drug resistance results from the selection of drug-resistant mutant bacilli following monotherapy [8], whether intentional or resulting from inadequate treatment [9].…”
mentioning
confidence: 99%